However, when many of the above variables are controlled for, studies with modest sample sizes (n = 5 to 17 cases) have clearly shown that glucose-stimulated insulin secretion (GSIS) is defective in islets from T2D donors, relative to non-diabetic donors [16-18]. The gene discussed is INS; the disease is type 2 diabetes mellitus.